Serum levels of IL-1beta, TNF-alpha, IL-8, and acute phase proteins in seronegative spondyloarthropathies

Joint Bone Spine

Volumn 69, Issue 5, 2002, Pages 463-467

  Sonel, Birkan ^a   Tutkak, H ^a   Düzgün, Nursen ^a  

^a Kirkpinar Sokak No: 25/8 06540   (Turkey)

Author keywords

Acute phase proteins; IL 1 beta; IL 8; Seronegative spondyloarthritis; TNF alpha

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; C REACTIVE PROTEIN; HAPTOGLOBIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; OROSOMUCOID; TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 1;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOPATHOLOGY; MALE; NEPHELOMETRY; SEROLOGY; SPONDYLOARTHROPATHY; BLOOD; IMMUNOLOGY; PATHOPHYSIOLOGY;

ACUTE-PHASE PROTEINS; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; MALE; SPONDYLARTHROPATHIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036813084     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(02)00431-1     Document Type: Article

References (23)

1. Khan MA. Spondyloarthropathies. Rheum Dis Clin North Am 1992; 18: 1-282.
2. Platanias LC, Vogelzang NJ. Interleukin-1: Biology, pathophysiology and clinical prospects. Am J Med 1990; 89: 621-9.
3. Beutler BA. The role of TNF in health and disease. J Rheumatol 1999; 6 (Suppl 57): 16-21.
4. Vassalli P. The pathophysiology of tumor necrosis factor. Annu Rev Immunol 1992; 10: 411-52.
5. Thoraton AJ, Strieter R, Lindley I, Baggiolini M, Kunkel SL. Cytokine induced gene expression of neutrophil chemotactic factor/interleukin-8 in human hepatocytes. J Immunol 1990; 144: 2600-13.
6. Duff GW. Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheum 1994; 23 (Suppl. 100): 9-19.
7. Nashel DJ, Petrone DL, Ulmer CC, Sliwinski AJ. C-reactive protein: A marker for disease activity in ankylosing spondilitis and Reiter syndrome. J Rheumatol 1986; 13: 364-7.
8. Brennan FM, Maini RV, Feldman M. Role of proinflammatory cytokines in rheumatoid arthritis. Springer Semin Immuno Pathol 1998; 20: 133-47.
9. Deleuran B, Lemche P, Kristensen M, Chu CQ, Field M, Jensen J, et al. Localisation of interleukin-8 in the synovial membrane, cartilage-pannus junction and chondrocytes in rheumatoid arthritis. Scand J Rheumatol 1993; 23: 2-7.
10. Amor B, Dougados M, Mijiyawa M. Critères de classification des spondyloarthropathies. Rev Rhum Mal Osteoartic 1990; 57: 85-9.
11. Standardised procedures for outcome measurement and parameters for calculating sample size for antirheumatic drug studies. In: Bellamy N, Ed. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers; 1993. p. 189-268.
12. Gratacos J, Collado A, Filella X, Sanmarti R, Canete J, Llena J, et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: A close correlation between serum IL-6 and disease activity and severity. Br J Med 1994; 33: 927-31.
13. Toussirot E, Lafforgue P, Boucraut J, Despieds P, Schiano A, Bernard D, et al. Serum levels of interleukin-1-beta, tumor necrosis factor-alpha, soluble interleukin-2 receptor and soluble CD8 in seronegative spondyloarthropathies. Rheum Int 1994; 13: 175-80.
14. Claudepierre P, Rymer JC, Authier FJ, Allonore Y, Larget-Piet B, Gherardi R, et al. A relationship between TGF-β1 or IL-6 plasma levels and clinical features of spondyloarthropathies. Br J Rheumatol 1997; 36: 400-1.
15. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistopathologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38: 499-505.
16. Jenkins JK, Malyak M, Arend WP. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res 1994; 13: 47-54.
17. Claudepierre P, Rymer J-C, Chevalier X. IL-10 plasma levels correlate with disease activity in spondylarthropathy. J Rheumatol 1997; 24: 1659-61.
18. Schwarz M, Radeke HH, Resch K, Uciechowski P. Lymphocyte-derived cytokines induce sequential expression of monocyte and T cell-specific chemokines in human mesengial cells. Kidney Int 1997; 52: 1521-31.
19. Rot A. Endothelial cell binding of NAPI/IL-8: Role in neutrophil migration. Immunol Today 1992; 51: 236-65.
20. Reynolds TL, Khan M, van der Linden S, Cleveland RP. Differences in HLA-B27 positive and negative patients with ankylosing spondylitis: Study of clinical activity and concentrations of serum IgA, C-reactive protein and haptoglobulin. Ann Rheum Dis 1991; 50: 154-7.
21. Nashel DJ, Petrone DL, Ulmer CC, Sliwinski AJ. C-reactive protein: A marker for disease activity in ankylosing spondylitis and Reiter's syndrome. J Rheumatol 1986; 13: 364-7.
22. Sheehan NJ, Slavin BM, Donavan MP, Mount JN, Mathwes JA. Lack of correlation between clinical disease activity and erythrocyte sedimentation rate, acute phase proteins and protease inhibitors in ankylosing spondylitis. Br J Rheumatol 1986; 25: 171-4.
23. Will R, Magaro L, Eiswood J, Colin A. Ankylosing Spondylitis (AS) and acute phase reactants. The elusive relationship. Br J Rheumatol 1989; 26: 11.